Lara Smith-Weber
President presso CONSTELLATION PHARMACEUTICALS, INC.
Profilo
Lara Smith-Weber is currently the President, Secretary & Treasurer at Constellation Pharmaceuticals, Inc. She previously worked as Senior VP-Controlling & Internal Controlling at MorphoSys AG, Head-Financial Planning & Analysis at MorphoSys US, Inc., and Chief Financial Officer at Onward Medical NV.
Ms. Smith-Weber received her undergraduate and graduate degrees from Stanford University and an MBA from the International Institute for Management Development.
Posizioni attive di Lara Smith-Weber
| Società | Posizione | Inizio |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | President | 15/07/2021 |
Precedenti posizioni note di Lara Smith-Weber
| Società | Posizione | Fine |
|---|---|---|
| ONWARD MEDICAL N.V. | Director of Finance/CFO | 01/10/2023 |
| MorphoSys US, Inc. | Corporate Officer/Principal | - |
| MORPHOSYS AG | Comptroller/Controller/Auditor | - |
Formazione di Lara Smith-Weber
| Stanford University | Graduate Degree |
| International Institute for Management Development | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MORPHOSYS AG | Health Technology |
| ONWARD MEDICAL N.V. | Commercial Services |
| Aziende private | 2 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MorphoSys US, Inc. |
- Borsa valori
- Insiders
- Lara Smith-Weber
